
### [MONDO:0004972](http://purl.obolibrary.org/obo/MONDO_0004972)
**Label:** adenoma

**Subclasses:** [MONDO:0003806](http://purl.obolibrary.org/obo/MONDO_0003806) (thyroid hyalinizing trabecular adenoma), [MONDO:0003924](http://purl.obolibrary.org/obo/MONDO_0003924) (adrenal cortex adenoma), [MONDO:0019392](http://purl.obolibrary.org/obo/MONDO_0019392) (syringocystadenoma papilliferum), [MONDO:0006634](http://purl.obolibrary.org/obo/MONDO_0006634) (pituitary gland acidophil adenoma), [MONDO:0006238](http://purl.obolibrary.org/obo/MONDO_0006238) (growth hormone-producing pituitary gland adenoma), [MONDO:0000530](http://purl.obolibrary.org/obo/MONDO_0000530) (rectum adenoma), [MONDO:0002395](http://purl.obolibrary.org/obo/MONDO_0002395) (renal adenoma), [MONDO:0021110](http://purl.obolibrary.org/obo/MONDO_0021110) (sweat gland adenoma), [MONDO:0018902](http://purl.obolibrary.org/obo/MONDO_0018902) (hepatocellular adenoma), [MONDO:0016035](http://purl.obolibrary.org/obo/MONDO_0016035) (Nelson syndrome), [MONDO:0003419](http://purl.obolibrary.org/obo/MONDO_0003419) (Bartholin's gland adenoma), [MONDO:0006408](http://purl.obolibrary.org/obo/MONDO_0006408) (sex hormone-producing adrenal cortex adenoma), [MONDO:0003893](http://purl.obolibrary.org/obo/MONDO_0003893) (rete testis adenoma), [MONDO:0004461](http://purl.obolibrary.org/obo/MONDO_0004461) (vaginal tubulovillous adenoma), [MONDO:0004462](http://purl.obolibrary.org/obo/MONDO_0004462) (extrahepatic bile duct cystadenoma), [MONDO:0006088](http://purl.obolibrary.org/obo/MONDO_0006088) (appendix adenoma), [MONDO:0005032](http://purl.obolibrary.org/obo/MONDO_0005032) (follicular thyroid adenoma), [MONDO:0004460](http://purl.obolibrary.org/obo/MONDO_0004460) (thyroid fetal adenoma), [MONDO:0007052](http://purl.obolibrary.org/obo/MONDO_0007052) (growth hormone secreting pituitary adenoma), [MONDO:0019933](http://purl.obolibrary.org/obo/MONDO_0019933) (acromegaly), [MONDO:0006859](http://purl.obolibrary.org/obo/MONDO_0006859) (mucinous cystadenoma), [MONDO:0020523](http://purl.obolibrary.org/obo/MONDO_0020523) (familial parathyroid adenoma), [MONDO:0002533](http://purl.obolibrary.org/obo/MONDO_0002533) (papillary adenoma), [MONDO:0004558](http://purl.obolibrary.org/obo/MONDO_0004558) (thyroid gland macrofollicular adenoma), [MONDO:0005248](http://purl.obolibrary.org/obo/MONDO_0005248) (adrenocortical adenoma (disease)), [MONDO:0006216](http://purl.obolibrary.org/obo/MONDO_0006216) (gallbladder adenoma), [MONDO:0002375](http://purl.obolibrary.org/obo/MONDO_0002375) (sebaceous adenoma), [MONDO:0005484](http://purl.obolibrary.org/obo/MONDO_0005484) (colorectal adenoma), [MONDO:0004273](http://purl.obolibrary.org/obo/MONDO_0004273) (breast apocrine adenoma), [MONDO:0006174](http://purl.obolibrary.org/obo/MONDO_0006174) (cortisol-producing adrenal cortex adenoma), [MONDO:0004270](http://purl.obolibrary.org/obo/MONDO_0004270) (breast ductal adenoma), [MONDO:0004271](http://purl.obolibrary.org/obo/MONDO_0004271) (pregnancy adenoma), [MONDO:0000525](http://purl.obolibrary.org/obo/MONDO_0000525) (cecum villous adenoma), [MONDO:0007718](http://purl.obolibrary.org/obo/MONDO_0007718) (hepatic adenomas, familial), [MONDO:0000527](http://purl.obolibrary.org/obo/MONDO_0000527) (colon adenoma), [MONDO:0003998](http://purl.obolibrary.org/obo/MONDO_0003998) (vaginal tubular adenoma), [MONDO:0020479](http://purl.obolibrary.org/obo/MONDO_0020479) (pituitary gigantism), [MONDO:0006108](http://purl.obolibrary.org/obo/MONDO_0006108) (bile duct adenoma), [MONDO:0003872](http://purl.obolibrary.org/obo/MONDO_0003872) (ovarian papillary cystadenoma), [MONDO:0006068](http://purl.obolibrary.org/obo/MONDO_0006068) (ACTH-producing pituitary gland adenoma), [MONDO:0006221](http://purl.obolibrary.org/obo/MONDO_0006221) (gastric adenoma), [MONDO:0006187](http://purl.obolibrary.org/obo/MONDO_0006187) (duodenal villous adenoma), [MONDO:0019927](http://purl.obolibrary.org/obo/MONDO_0019927) (growth hormone-producing pituitary gland neoplasm), [MONDO:0009050](http://purl.obolibrary.org/obo/MONDO_0009050) (ACTH-secreting pituitary adenoma), [MONDO:0006180](http://purl.obolibrary.org/obo/MONDO_0006180) (digestive system adenoma), [MONDO:0003609](http://purl.obolibrary.org/obo/MONDO_0003609) (seminal vesicle cystadenoma), [MONDO:0001422](http://purl.obolibrary.org/obo/MONDO_0001422) (Conn's syndrome), [MONDO:0003446](http://purl.obolibrary.org/obo/MONDO_0003446) (papillary hidradenoma), [MONDO:0003447](http://purl.obolibrary.org/obo/MONDO_0003447) (clear cell hidradenoma), [MONDO:0003444](http://purl.obolibrary.org/obo/MONDO_0003444) (intrahepatic bile duct adenoma), [MONDO:0003565](http://purl.obolibrary.org/obo/MONDO_0003565) (urethral villous adenoma), [MONDO:0003445](http://purl.obolibrary.org/obo/MONDO_0003445) (extrahepatic bile duct adenoma), [MONDO:0021271](http://purl.obolibrary.org/obo/MONDO_0021271) (villous adenoma of colon), [MONDO:0004136](http://purl.obolibrary.org/obo/MONDO_0004136) (ovarian endometrioid cystadenoma), [MONDO:0004133](http://purl.obolibrary.org/obo/MONDO_0004133) (pituitary gland mixed eosinophil-basophil adenoma), [MONDO:0006156](http://purl.obolibrary.org/obo/MONDO_0006156) (colon sessile serrated adenoma/polyp), [MONDO:0006673](http://purl.obolibrary.org/obo/MONDO_0006673) (pituitary gland basophil adenoma), [MONDO:0002197](http://purl.obolibrary.org/obo/MONDO_0002197) (minor vestibular glands adenoma), [MONDO:0006396](http://purl.obolibrary.org/obo/MONDO_0006396) (rectal villous adenoma), [MONDO:0004250](http://purl.obolibrary.org/obo/MONDO_0004250) (extrahepatic bile duct papillary adenoma), [MONDO:0006395](http://purl.obolibrary.org/obo/MONDO_0006395) (rectal tubulovillous adenoma), [MONDO:0006394](http://purl.obolibrary.org/obo/MONDO_0006394) (rectal tubular adenoma), [MONDO:0005183](http://purl.obolibrary.org/obo/MONDO_0005183) (ovarian cystadenoma), [MONDO:0006393](http://purl.obolibrary.org/obo/MONDO_0006393) (rectal traditional serrated adenoma), [MONDO:0006391](http://purl.obolibrary.org/obo/MONDO_0006391) (pyloric gland adenoma), [MONDO:0016525](http://purl.obolibrary.org/obo/MONDO_0016525) (familial hyperaldosteronism), [MONDO:0002809](http://purl.obolibrary.org/obo/MONDO_0002809) (pancreatic cystadenoma), [MONDO:0010492](http://purl.obolibrary.org/obo/MONDO_0010492) (pituitary adenoma, growth hormone-secreting, 2), [MONDO:0002805](http://purl.obolibrary.org/obo/MONDO_0002805) (hidradenoma), [MONDO:0002808](http://purl.obolibrary.org/obo/MONDO_0002808) (pancreatic serous cystadenoma), [MONDO:0000502](http://purl.obolibrary.org/obo/MONDO_0000502) (villous adenoma), [MONDO:0021301](http://purl.obolibrary.org/obo/MONDO_0021301) (adenoma of nipple), [MONDO:0003979](http://purl.obolibrary.org/obo/MONDO_0003979) (intrahepatic bile duct cystadenoma), [MONDO:0002369](http://purl.obolibrary.org/obo/MONDO_0002369) (cystadenoma), [MONDO:0021303](http://purl.obolibrary.org/obo/MONDO_0021303) (adenoma of small intestine), [MONDO:0004428](http://purl.obolibrary.org/obo/MONDO_0004428) (alveoli adenoma), [MONDO:0003611](http://purl.obolibrary.org/obo/MONDO_0003611) (uterine ligament papillary cystadenoma associated with von hippel-lindau disease), [MONDO:0004304](http://purl.obolibrary.org/obo/MONDO_0004304) (mixed cell type adenoma of parathyroid), [MONDO:0004305](http://purl.obolibrary.org/obo/MONDO_0004305) (parathyroid oncocytic adenoma), [MONDO:0004302](http://purl.obolibrary.org/obo/MONDO_0004302) (chief cell adenoma), [MONDO:0003610](http://purl.obolibrary.org/obo/MONDO_0003610) (rete ovarii cystadenoma), [MONDO:0002364](http://purl.obolibrary.org/obo/MONDO_0002364) (Wolffian duct adenoma), [MONDO:0004303](http://purl.obolibrary.org/obo/MONDO_0004303) (parathyroid gland clear cell adenoma), [MONDO:0006321](http://purl.obolibrary.org/obo/MONDO_0006321) (non-functioning adrenal cortex adenoma), [MONDO:0006164](http://purl.obolibrary.org/obo/MONDO_0006164) (colorectal sessile serrated adenoma/polyp), [MONDO:0014200](http://purl.obolibrary.org/obo/MONDO_0014200) (aldosterone-producing adenoma with seizures and neurological abnormalities), [MONDO:0018523](http://purl.obolibrary.org/obo/MONDO_0018523) (pancreatic mucinous cystadenoma), [MONDO:0019612](http://purl.obolibrary.org/obo/MONDO_0019612) (functioning gonadotropic adenoma), [MONDO:0019613](http://purl.obolibrary.org/obo/MONDO_0019613) (non-functioning pituitary adenoma), [MONDO:0019611](http://purl.obolibrary.org/obo/MONDO_0019611) (TSH-secreting pituitary adenoma), [MONDO:0003828](http://purl.obolibrary.org/obo/MONDO_0003828) (growth hormone-producing pituitary gland carcinoma), [MONDO:0003829](http://purl.obolibrary.org/obo/MONDO_0003829) (chromophil adenoma of the kidney), [MONDO:0003946](http://purl.obolibrary.org/obo/MONDO_0003946) (vaginal villous adenoma), [MONDO:0003429](http://purl.obolibrary.org/obo/MONDO_0003429) (functioning pituitary gland adenoma), [MONDO:0003426](http://purl.obolibrary.org/obo/MONDO_0003426) (clear cell adenoma), [MONDO:0003427](http://purl.obolibrary.org/obo/MONDO_0003427) (bronchus adenoma), [MONDO:0003424](http://purl.obolibrary.org/obo/MONDO_0003424) (oncocytic adenoma), [MONDO:0003422](http://purl.obolibrary.org/obo/MONDO_0003422) (lung adenoma), [MONDO:0003423](http://purl.obolibrary.org/obo/MONDO_0003423) (middle ear adenoma), [MONDO:0005048](http://purl.obolibrary.org/obo/MONDO_0005048) (insulinoma (disease)), [MONDO:0003420](http://purl.obolibrary.org/obo/MONDO_0003420) (bile duct cystadenoma), [MONDO:0002058](http://purl.obolibrary.org/obo/MONDO_0002058) (breast adenoma), [MONDO:0003421](http://purl.obolibrary.org/obo/MONDO_0003421) (mixed cell adenoma), [MONDO:0002454](http://purl.obolibrary.org/obo/MONDO_0002454) (thyroid adenoma (disease)), [MONDO:0006498](http://purl.obolibrary.org/obo/MONDO_0006498) (adenomatous colon polyp), [MONDO:0004079](http://purl.obolibrary.org/obo/MONDO_0004079) (bronchial mucus gland adenoma), [MONDO:0002450](http://purl.obolibrary.org/obo/MONDO_0002450) (prostatic adenoma), [MONDO:0016508](http://purl.obolibrary.org/obo/MONDO_0016508) (rare non surgically correctable form of primary aldosteronism), [MONDO:0006373](http://purl.obolibrary.org/obo/MONDO_0006373) (pituitary gland adenoma), [MONDO:0006890](http://purl.obolibrary.org/obo/MONDO_0006890) (parathyroid gland adenoma), [MONDO:0016507](http://purl.obolibrary.org/obo/MONDO_0016507) (rare surgically correctable form of primary aldosteronism), [MONDO:0011576](http://purl.obolibrary.org/obo/MONDO_0011576) (familial hyperaldosteronism type II), [MONDO:0006493](http://purl.obolibrary.org/obo/MONDO_0006493) (Warthin tumor), [MONDO:0015899](http://purl.obolibrary.org/obo/MONDO_0015899) (rare primary hyperaldosteronism), [MONDO:0016504](http://purl.obolibrary.org/obo/MONDO_0016504) (primary unilateral adrenal hyperplasia), [MONDO:0016506](http://purl.obolibrary.org/obo/MONDO_0016506) (ectopic aldosterone-producing tumor), [MONDO:0013359](http://purl.obolibrary.org/obo/MONDO_0013359) (familial hyperaldosteronism type III), [MONDO:0021091](http://purl.obolibrary.org/obo/MONDO_0021091) (papillary cystadenoma), [MONDO:0006092](http://purl.obolibrary.org/obo/MONDO_0006092) (appendix villous adenoma), [MONDO:0016505](http://purl.obolibrary.org/obo/MONDO_0016505) (adrenocortical carcinoma with pure aldosterone hypersecretion), [MONDO:0007080](http://purl.obolibrary.org/obo/MONDO_0007080) (glucocorticoid-remediable aldosteronism), [MONDO:0017822](http://purl.obolibrary.org/obo/MONDO_0017822) (mixed functioning pituitary adenoma), [MONDO:0003837](http://purl.obolibrary.org/obo/MONDO_0003837) (TSH producing pituitary tumor), [MONDO:0003439](http://purl.obolibrary.org/obo/MONDO_0003439) (urinary bladder villous adenoma), [MONDO:0003836](http://purl.obolibrary.org/obo/MONDO_0003836) (malignant thyroid stimulating hormone producing neoplasm of pituitary gland), [MONDO:0003831](http://purl.obolibrary.org/obo/MONDO_0003831) (type 2 papillary adenoma of the kidney), [MONDO:0006307](http://purl.obolibrary.org/obo/MONDO_0006307) (mixed somatotroph-lactotroph pituitary gland adenoma), [MONDO:0003435](http://purl.obolibrary.org/obo/MONDO_0003435) (microcystic adenoma), [MONDO:0004524](http://purl.obolibrary.org/obo/MONDO_0004524) (atypical follicular adenoma), [MONDO:0004005](http://purl.obolibrary.org/obo/MONDO_0004005) (rete ovarii adenoma), [MONDO:0006701](http://purl.obolibrary.org/obo/MONDO_0006701) (chromophobe adenoma), [MONDO:0003433](http://purl.obolibrary.org/obo/MONDO_0003433) (water-clear cell adenoma), [MONDO:0002189](http://purl.obolibrary.org/obo/MONDO_0002189) (nodular hidradenoma), [MONDO:0002188](http://purl.obolibrary.org/obo/MONDO_0002188) (vulvar nodular hidradenoma), [MONDO:0003434](http://purl.obolibrary.org/obo/MONDO_0003434) (vaginal adenoma), [MONDO:0003830](http://purl.obolibrary.org/obo/MONDO_0003830) (type 1 papillary adenoma of the kidney), [MONDO:0003431](http://purl.obolibrary.org/obo/MONDO_0003431) (lipoadenoma), [MONDO:0006149](http://purl.obolibrary.org/obo/MONDO_0006149) (clear cell papillary cystadenoma), [MONDO:0005332](http://purl.obolibrary.org/obo/MONDO_0005332) (growth hormone-secreting pituitary adenoma), [MONDO:0006301](http://purl.obolibrary.org/obo/MONDO_0006301) (metanephric adenoma), [MONDO:0006422](http://purl.obolibrary.org/obo/MONDO_0006422) (small intestinal tubulovillous adenoma), [MONDO:0006421](http://purl.obolibrary.org/obo/MONDO_0006421) (small intestinal tubular adenoma), [MONDO:0005179](http://purl.obolibrary.org/obo/MONDO_0005179) (ovarian adenoma benign), [MONDO:0002583](http://purl.obolibrary.org/obo/MONDO_0002583) (mucinous ovarian cystadenoma), [MONDO:0004483](http://purl.obolibrary.org/obo/MONDO_0004483) (thyroid gland oncocytic adenoma), [MONDO:0005177](http://purl.obolibrary.org/obo/MONDO_0005177) (serous cystadenoma), [MONDO:0006023](http://purl.obolibrary.org/obo/MONDO_0006023) (aldosterone-producing adenoma), [MONDO:0017824](http://purl.obolibrary.org/obo/MONDO_0017824) (familial isolated pituitary adenoma), [MONDO:0010911](http://purl.obolibrary.org/obo/MONDO_0010911) (prolactin-producing pituitary gland adenoma), [MONDO:0017823](http://purl.obolibrary.org/obo/MONDO_0017823) (Somatomammotropinoma), [MONDO:0017826](http://purl.obolibrary.org/obo/MONDO_0017826) (null pituitary adenoma), [MONDO:0017825](http://purl.obolibrary.org/obo/MONDO_0017825) (silent pituitary adenoma), 

**Mapped go classes:** [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0008104](http://purl.obolibrary.org/obo/GO_0008104) (protein localization), [GO:0009952](http://purl.obolibrary.org/obo/GO_0009952) (anterior/posterior pattern specification), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0000977](http://purl.obolibrary.org/obo/GO_0000977) (RNA polymerase II regulatory region sequence-specific DNA binding), [GO:0050796](http://purl.obolibrary.org/obo/GO_0050796) (regulation of insulin secretion), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0004935](http://purl.obolibrary.org/obo/GO_0004935) (adrenergic receptor activity), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0005506](http://purl.obolibrary.org/obo/GO_0005506) (iron ion binding), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0042383](http://purl.obolibrary.org/obo/GO_0042383) (sarcolemma), [GO:0019001](http://purl.obolibrary.org/obo/GO_0019001) (guanyl nucleotide binding), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0001824](http://purl.obolibrary.org/obo/GO_0001824) (blastocyst development), [GO:0001706](http://purl.obolibrary.org/obo/GO_0001706) (endoderm formation), [GO:0007267](http://purl.obolibrary.org/obo/GO_0007267) (cell-cell signaling), [GO:0005242](http://purl.obolibrary.org/obo/GO_0005242) (inward rectifier potassium channel activity), [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity), [GO:0021667](http://purl.obolibrary.org/obo/GO_0021667) (rhombomere 6 morphogenesis), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0005244](http://purl.obolibrary.org/obo/GO_0005244) (voltage-gated ion channel activity), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0006694](http://purl.obolibrary.org/obo/GO_0006694) (steroid biosynthetic process), [GO:0006699](http://purl.obolibrary.org/obo/GO_0006699) (bile acid biosynthetic process), [GO:0005245](http://purl.obolibrary.org/obo/GO_0005245) (voltage-gated calcium channel activity), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0045777](http://purl.obolibrary.org/obo/GO_0045777) (positive regulation of blood pressure), [GO:0021664](http://purl.obolibrary.org/obo/GO_0021664) (rhombomere 5 morphogenesis), [GO:0031748](http://purl.obolibrary.org/obo/GO_0031748) (D1 dopamine receptor binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0072576](http://purl.obolibrary.org/obo/GO_0072576) (liver morphogenesis), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0071880](http://purl.obolibrary.org/obo/GO_0071880) (adenylate cyclase-activating adrenergic receptor signaling pathway), [GO:0035148](http://purl.obolibrary.org/obo/GO_0035148) (tube formation), [GO:0086010](http://purl.obolibrary.org/obo/GO_0086010) (membrane depolarization during action potential), [GO:0007191](http://purl.obolibrary.org/obo/GO_0007191) (adenylate cyclase-activating dopamine receptor signaling pathway), [GO:0055075](http://purl.obolibrary.org/obo/GO_0055075) (potassium ion homeostasis), [GO:0060261](http://purl.obolibrary.org/obo/GO_0060261) (positive regulation of transcription initiation from RNA polymerase II promoter), [GO:0055078](http://purl.obolibrary.org/obo/GO_0055078) (sodium ion homeostasis), [GO:0008203](http://purl.obolibrary.org/obo/GO_0008203) (cholesterol metabolic process), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0006783](http://purl.obolibrary.org/obo/GO_0006783) (heme biosynthetic process), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0001890](http://purl.obolibrary.org/obo/GO_0001890) (placenta development), [GO:0097470](http://purl.obolibrary.org/obo/GO_0097470) (ribbon synapse), [GO:0006700](http://purl.obolibrary.org/obo/GO_0006700) (C21-steroid hormone biosynthetic process), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0006813](http://purl.obolibrary.org/obo/GO_0006813) (potassium ion transport), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:0009925](http://purl.obolibrary.org/obo/GO_0009925) (basal plasma membrane), [GO:0046883](http://purl.obolibrary.org/obo/GO_0046883) (regulation of hormone secretion), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0006816](http://purl.obolibrary.org/obo/GO_0006816) (calcium ion transport), [GO:0070588](http://purl.obolibrary.org/obo/GO_0070588) (calcium ion transmembrane transport), [GO:0031852](http://purl.obolibrary.org/obo/GO_0031852) (mu-type opioid receptor binding), [GO:0031698](http://purl.obolibrary.org/obo/GO_0031698) (beta-2 adrenergic receptor binding), [GO:0050974](http://purl.obolibrary.org/obo/GO_0050974) (detection of mechanical stimulus involved in sensory perception), [GO:0016579](http://purl.obolibrary.org/obo/GO_0016579) (protein deubiquitination), [GO:0035255](http://purl.obolibrary.org/obo/GO_0035255) (ionotropic glutamate receptor binding), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0008331](http://purl.obolibrary.org/obo/GO_0008331) (high voltage-gated calcium channel activity), [GO:0048546](http://purl.obolibrary.org/obo/GO_0048546) (digestive tract morphogenesis), [GO:0004497](http://purl.obolibrary.org/obo/GO_0004497) (monooxygenase activity), [GO:0008217](http://purl.obolibrary.org/obo/GO_0008217) (regulation of blood pressure), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0003323](http://purl.obolibrary.org/obo/GO_0003323) (type B pancreatic cell development), [GO:0020037](http://purl.obolibrary.org/obo/GO_0020037) (heme binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005216](http://purl.obolibrary.org/obo/GO_0005216) (ion channel activity), [GO:0006704](http://purl.obolibrary.org/obo/GO_0006704) (glucocorticoid biosynthetic process), [GO:0051430](http://purl.obolibrary.org/obo/GO_0051430) (corticotropin-releasing hormone receptor 1 binding), [GO:1990798](http://purl.obolibrary.org/obo/GO_1990798) (pancreas regeneration), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0001779](http://purl.obolibrary.org/obo/GO_0001779) (natural killer cell differentiation), [GO:0030916](http://purl.obolibrary.org/obo/GO_0030916) (otic vesicle formation), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0031683](http://purl.obolibrary.org/obo/GO_0031683) (G-protein beta/gamma-subunit complex binding), [GO:0030111](http://purl.obolibrary.org/obo/GO_0030111) (regulation of Wnt signaling pathway), [GO:0036459](http://purl.obolibrary.org/obo/GO_0036459) (thiol-dependent ubiquitinyl hydrolase activity), [GO:0030073](http://purl.obolibrary.org/obo/GO_0030073) (insulin secretion), [GO:0034672](http://purl.obolibrary.org/obo/GO_0034672) (anterior/posterior pattern specification involved in pronephros development), [GO:0006366](http://purl.obolibrary.org/obo/GO_0006366) (transcription by RNA polymerase II), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0001228](http://purl.obolibrary.org/obo/GO_0001228) (transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0001991](http://purl.obolibrary.org/obo/GO_0001991) (regulation of systemic arterial blood pressure by circulatory renin-angiotensin), [GO:0005159](http://purl.obolibrary.org/obo/GO_0005159) (insulin-like growth factor receptor binding), [GO:0001750](http://purl.obolibrary.org/obo/GO_0001750) (photoreceptor outer segment), [GO:0007606](http://purl.obolibrary.org/obo/GO_0007606) (sensory perception of chemical stimulus), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0009749](http://purl.obolibrary.org/obo/GO_0009749) (response to glucose), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0001588](http://purl.obolibrary.org/obo/GO_0001588) (dopamine neurotransmitter receptor activity, coupled via Gs), [GO:0048566](http://purl.obolibrary.org/obo/GO_0048566) (embryonic digestive tract development), [GO:0015908](http://purl.obolibrary.org/obo/GO_0015908) (fatty acid transport), [GO:0048840](http://purl.obolibrary.org/obo/GO_0048840) (otolith development), [GO:0030902](http://purl.obolibrary.org/obo/GO_0030902) (hindbrain development), [GO:0045453](http://purl.obolibrary.org/obo/GO_0045453) (bone resorption), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0016573](http://purl.obolibrary.org/obo/GO_0016573) (histone acetylation), [GO:0050910](http://purl.obolibrary.org/obo/GO_0050910) (detection of mechanical stimulus involved in sensory perception of sound), [GO:0016853](http://purl.obolibrary.org/obo/GO_0016853) (isomerase activity), [GO:0031313](http://purl.obolibrary.org/obo/GO_0031313) (extrinsic component of endosome membrane), [GO:0048608](http://purl.obolibrary.org/obo/GO_0048608) (reproductive structure development), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0050808](http://purl.obolibrary.org/obo/GO_0050808) (synapse organization), [GO:0060395](http://purl.obolibrary.org/obo/GO_0060395) (SMAD protein signal transduction), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0061008](http://purl.obolibrary.org/obo/GO_0061008) (hepaticobiliary system development), [GO:0005834](http://purl.obolibrary.org/obo/GO_0005834) (heterotrimeric G-protein complex), [GO:0042593](http://purl.obolibrary.org/obo/GO_0042593) (glucose homeostasis), [GO:0004507](http://purl.obolibrary.org/obo/GO_0004507) (steroid 11-beta-monooxygenase activity), [GO:0032474](http://purl.obolibrary.org/obo/GO_0032474) (otolith morphogenesis), [GO:0010107](http://purl.obolibrary.org/obo/GO_0010107) (potassium ion import), [GO:0050801](http://purl.obolibrary.org/obo/GO_0050801) (ion homeostasis), [GO:0035622](http://purl.obolibrary.org/obo/GO_0035622) (intrahepatic bile duct development), [GO:0050885](http://purl.obolibrary.org/obo/GO_0050885) (neuromuscular process controlling balance), [GO:0035623](http://purl.obolibrary.org/obo/GO_0035623) (renal glucose absorption), [GO:0042756](http://purl.obolibrary.org/obo/GO_0042756) (drinking behavior), [GO:0034651](http://purl.obolibrary.org/obo/GO_0034651) (cortisol biosynthetic process), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0016705](http://purl.obolibrary.org/obo/GO_0016705) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen), [GO:0034650](http://purl.obolibrary.org/obo/GO_0034650) (cortisol metabolic process), [GO:0005891](http://purl.obolibrary.org/obo/GO_0005891) (voltage-gated calcium channel complex), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0043049](http://purl.obolibrary.org/obo/GO_0043049) (otic placode formation), [GO:0021575](http://purl.obolibrary.org/obo/GO_0021575) (hindbrain morphogenesis), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0006979](http://purl.obolibrary.org/obo/GO_0006979) (response to oxidative stress), [GO:0030326](http://purl.obolibrary.org/obo/GO_0030326) (embryonic limb morphogenesis), [GO:0048341](http://purl.obolibrary.org/obo/GO_0048341) (paraxial mesoderm formation), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0006338](http://purl.obolibrary.org/obo/GO_0006338) (chromatin remodeling), [GO:0002017](http://purl.obolibrary.org/obo/GO_0002017) (regulation of blood volume by renal aldosterone), [GO:0043691](http://purl.obolibrary.org/obo/GO_0043691) (reverse cholesterol transport), [GO:0034765](http://purl.obolibrary.org/obo/GO_0034765) (regulation of ion transmembrane transport), [GO:0032342](http://purl.obolibrary.org/obo/GO_0032342) (aldosterone biosynthetic process), [GO:0031018](http://purl.obolibrary.org/obo/GO_0031018) (endocrine pancreas development), [GO:0015721](http://purl.obolibrary.org/obo/GO_0015721) (bile acid and bile salt transport), [GO:0031016](http://purl.obolibrary.org/obo/GO_0031016) (pancreas development), [GO:0015467](http://purl.obolibrary.org/obo/GO_0015467) (G-protein activated inward rectifier potassium channel activity), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0005262](http://purl.obolibrary.org/obo/GO_0005262) (calcium channel activity), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0046323](http://purl.obolibrary.org/obo/GO_0046323) (glucose import), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0006633](http://purl.obolibrary.org/obo/GO_0006633) (fatty acid biosynthetic process), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0006511](http://purl.obolibrary.org/obo/GO_0006511) (ubiquitin-dependent protein catabolic process), [GO:0001221](http://purl.obolibrary.org/obo/GO_0001221) (transcription cofactor binding), [GO:0003755](http://purl.obolibrary.org/obo/GO_0003755) (peptidyl-prolyl cis-trans isomerase activity), [GO:0021571](http://purl.obolibrary.org/obo/GO_0021571) (rhombomere 5 development), [GO:0021572](http://purl.obolibrary.org/obo/GO_0021572) (rhombomere 6 development), [GO:0048752](http://purl.obolibrary.org/obo/GO_0048752) (semicircular canal morphogenesis), [GO:0045120](http://purl.obolibrary.org/obo/GO_0045120) (pronucleus), [GO:0047783](http://purl.obolibrary.org/obo/GO_0047783) (corticosterone 18-monooxygenase activity), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), 

**Class expressions from DL-Learner:**

- Thing 54.91%
- [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity) 51.69%
- [GO:0051430](http://purl.obolibrary.org/obo/GO_0051430) (corticotropin-releasing hormone receptor 1 binding) 50.85%
- [GO:0051429](http://purl.obolibrary.org/obo/GO_0051429) (corticotropin-releasing hormone receptor binding) 50.85%
- [GO:0051428](http://purl.obolibrary.org/obo/GO_0051428) (peptide hormone receptor binding) 50.85%
- [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity) 50.85%
- [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity) 50.85%
- [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding) 50.85%
- [GO:0035255](http://purl.obolibrary.org/obo/GO_0035255) (ionotropic glutamate receptor binding) 50.85%
- [GO:0031852](http://purl.obolibrary.org/obo/GO_0031852) (mu-type opioid receptor binding) 50.85%
- [GO:0031748](http://purl.obolibrary.org/obo/GO_0031748) (D1 dopamine receptor binding) 50.85%
- [GO:0031698](http://purl.obolibrary.org/obo/GO_0031698) (beta-2 adrenergic receptor binding) 50.85%
- [GO:0031690](http://purl.obolibrary.org/obo/GO_0031690) (adrenergic receptor binding) 50.85%
- [GO:0031683](http://purl.obolibrary.org/obo/GO_0031683) (G-protein beta/gamma-subunit complex binding) 50.85%
- [GO:0031628](http://purl.obolibrary.org/obo/GO_0031628) (opioid receptor binding) 50.85%


